Rationale and Status of “At Risk” Moderate AS Trials (PROGRESS and EXPAND TAVR II)

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Grant Support/Research Contract - Abbott; Edwards Lifesciences; Boston Scientific Corporation
• Consultant Fee/Honoraria/Speaker's Bureau - Cordis Corporation, a Johnson & Johnson company; Medtronic
• Salary/Salary Support/Employee - Cedars-Sinai Medical Center